| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 04/18/2000 | US6051683 Immune regulating peptides and method of obtaining them |
| 04/18/2000 | US6051588 Which have significantly reduced gastrointestinal side effects |
| 04/18/2000 | US6051568 Thrombin inhibitors, their preparation and use |
| 04/13/2000 | WO2000020440A1 Caspases and apoptosis |
| 04/13/2000 | WO2000020437A1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism |
| 04/13/2000 | WO2000020112A2 Chemical constructs and their uses |
| 04/13/2000 | WO2000000509A3 Peptides for inhibiting hpv e7 proteins |
| 04/13/2000 | DE19845403A1 Mit Gallensäuren verknüpfte Porpanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung With bile acids linked Porpanolaminderivate, processes for their preparation, pharmaceutical compositions containing them and their use |
| 04/13/2000 | CA2346085A1 Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism |
| 04/12/2000 | EP0992501A2 Pyridonecarboxylic acid derivatives as antibacterial agents |
| 04/12/2000 | EP0992492A1 Small molecule inhibitors of rotamase enzyme activity |
| 04/12/2000 | EP0991753A1 Protease inhibitors |
| 04/12/2000 | EP0909176A4 Reactor and method for solid phase peptide synthesis |
| 04/12/2000 | EP0668776B1 Memory enhancing substances |
| 04/11/2000 | US6048999 Artificial sweetener |
| 04/11/2000 | US6048889 Proline derivatives |
| 04/11/2000 | US6048858 Heteroring containing a sulfonamide group |
| 04/11/2000 | US6048840 Hypoglycaemic peptides |
| 04/11/2000 | CA2174314C Electrophilic peptide analogs as inhibitors of trypsin-like enzymes |
| 04/11/2000 | CA2016663C Enzyme inhibiting peptide derivatives |
| 04/11/2000 | CA2016656C Enzyme inhibitors |
| 04/11/2000 | CA1340957C Nikkomycin derivatives, antimycotic compositions of nikkomycin derivatives and azole antimycotics |
| 04/06/2000 | WO2000019210A2 Determining the mechanism of beta-amyloid peptide generation |
| 04/06/2000 | WO2000018790A1 Synthesis of cyclic peptides |
| 04/06/2000 | WO2000018762A1 Thrombin inhibitors |
| 04/06/2000 | WO2000018418A2 Inhibition of erythrocyte sickling by n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester |
| 04/06/2000 | CA2345407A1 Synthesis of cyclic peptides |
| 04/06/2000 | CA2345243A1 Inhibition of erythrocyte sickling by n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester |
| 04/06/2000 | CA2343109A1 Thrombin inhibitors |
| 04/05/2000 | EP0989994A1 Streptogramines, their preparation and compositions containing them |
| 04/05/2000 | EP0989993A1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 04/05/2000 | EP0832100B1 Novel inhibitors of metalloproteases and pharmaceutical compositions comprising same |
| 04/05/2000 | EP0750631B1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 04/05/2000 | EP0740791A4 Systematic modular production of aminimide- and oxazolone-based molecules having selected properties |
| 04/05/2000 | CN1051083C Novel substd. puriny derivs. with immunomodulating activity |
| 04/04/2000 | US6046340 Imidazole containing pseudodipeptide product and compositions containing the same |
| 04/04/2000 | US6046289 For inhibiting coagulation of blood platelets, inhibiting adhesion of animal cells, or as substrate for culturing animal cells |
| 04/04/2000 | US6046219 Administering to the patient for treating the conditions mediated by collagen formation together with cell proliferation a hydroxypyridine derivative |
| 04/04/2000 | US6046169 Inhibitors of factor XA |
| 04/04/2000 | US6046168 Peptide inhibits blood triglyceride level |
| 04/04/2000 | US6046167 For controlling biological activities such as cell proliferation, nutrient transport, lipolysis, and intestinal water and electrolyte secretion |
| 04/04/2000 | CA2017565C Feed composition for culturing fishes |
| 04/04/2000 | CA1340948C Peptidylaminodiols |
| 04/04/2000 | CA1340940C Peptidylaminodiols |
| 03/30/2000 | WO2000017369A2 Alzheimer's disease secretase |
| 03/30/2000 | WO2000017231A1 Ethylamine derivatives |
| 03/30/2000 | WO2000017230A1 N-alkylaspartyldipeptide ester derivatives and sweeteners |
| 03/30/2000 | WO2000017229A1 Process for the preparation of n2-(1(s)-carboxy-3-phenylpropyl)-l-lysyl-l-proline |
| 03/30/2000 | WO2000017228A2 Stereoselective process for enalapril |
| 03/30/2000 | WO2000016807A1 Cationic compounds and their use as macro molecular carriers |
| 03/30/2000 | WO2000016767A1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 03/30/2000 | WO2000000214A3 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 03/30/2000 | CA2344314A1 N-alkylaspartyl dipeptide ester derivative and sweetening agent |
| 03/30/2000 | CA2343193A1 Improved stereoselective process for enalapril |
| 03/30/2000 | CA2343004A1 Alzheimer's disease secretase |
| 03/30/2000 | CA2311407A1 Process for the preparation of n2-(1(s)-carboxy-3-phenylpropyl)-l-lysyl-l-proline |
| 03/29/2000 | EP0988280A1 Hydroxamic acid compounds having anticancer and anti-parasitic properties |
| 03/28/2000 | US6043357 Stability, efficiency; treating human immuno deficiency viurs |
| 03/28/2000 | US6043233 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 03/28/2000 | US6043232 Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs |
| 03/28/2000 | US6043217 Antibacterial activity against methicillin-resistant staphylococcus aureus (mrsa). |
| 03/28/2000 | CA2164712C Trifunctional antithrombin and antiplatelet peptides |
| 03/23/2000 | WO2000015658A1 FACTOR VIIa INHIBITORS |
| 03/23/2000 | WO2000015657A1 Piperizine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and 53 |
| 03/23/2000 | WO2000015656A1 Process for the preparation of neotame |
| 03/23/2000 | WO2000015605A2 Chiral cyanoamines and methods of preparation |
| 03/23/2000 | WO2000015214A1 Fc RECEPTOR MODULATORS AND USES THEREOF |
| 03/23/2000 | WO2000015050A1 CO-CRYSTALLIZATION OF SUGAR AND N-[N-(3,3-DIMETHYLBUTYL)-1-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER |
| 03/23/2000 | WO2000006747A3 Enzymes for biopolymer production |
| 03/23/2000 | CA2344048A1 Factor viia inhibitors |
| 03/23/2000 | CA2343114A1 Process for the preparation of neotame |
| 03/22/2000 | EP0987275A2 Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
| 03/22/2000 | EP0987274A1 Factor VIIa Inhibitors |
| 03/22/2000 | EP0986754A1 Synthetic antibiotics |
| 03/22/2000 | EP0986575A1 Method for preparing salts of aspartame from n-protected aspartame |
| 03/22/2000 | EP0598129B1 Novel tetrapeptide derivative |
| 03/22/2000 | CN1247984A Diagnostic marking for human diseases |
| 03/21/2000 | US6040328 Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use |
| 03/21/2000 | US6040193 Combinatorial strategies for polymer synthesis |
| 03/16/2000 | WO2000014265A1 Enzymatic oxidative deamination process |
| 03/16/2000 | WO2000014110A1 CRYSTALLINE FORMS OF EtO2C-CH2-(R)Cgl-Aze-Pab-OH |
| 03/16/2000 | WO2000014109A1 Basic products having antagonistic activity on the nk-1 receptor and their use in pharmaceutical compositions |
| 03/16/2000 | CA2342792A1 Enzymatic oxidative deamination process |
| 03/16/2000 | CA2341259A1 Crystalline forms of eto2c-ch2-(r)cgl-aze-pab-oh |
| 03/15/2000 | EP0984981A1 Anti-inflammatory tyrosine derivatives |
| 03/15/2000 | EP0739204A4 Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
| 03/15/2000 | EP0656008B1 Thrombin receptor antagonists |
| 03/15/2000 | CN1247542A Serine protease inhibitors |
| 03/14/2000 | US6037472 For treating disease-states characterized by excessive activity of matrix metalloproteases such as rheumatoid arthritis, osteoarthritis, periodontal disease, aberrant angiogenesis, tumor invasion and metastasis |
| 03/14/2000 | US6037363 Respiratory system disorders, cystic fibrosis |
| 03/14/2000 | US6037356 Anticoagulants; antiinflammatory and antiarthritic agents |
| 03/14/2000 | US6037325 Certain substituted oxadiazole, thiadiazole and triazole peptoids used effectively to prevent, alleviate or otherwise treat disease states characterized by the degradation of connective tissue such as respiratory system disorders and |
| 03/14/2000 | US6037324 Madcam-1 (mucosal addressin cell adhesion molecule-1); useful in the treatment of inflammatory bowel diseases and other diseases involving leukocyte infiltration of the gastrointestinal tract or other mucosal tissues |
| 03/09/2000 | WO2000013026A1 Energy transfer dyes |
| 03/09/2000 | WO2000012547A2 Benzodiazepines and benzothiazepines derivatives and hbsag peptides binding to annexins, their compositions and use |
| 03/09/2000 | WO2000012539A1 Peptide compounds |
| 03/09/2000 | WO2000012524A1 Purification of oligomers using dual-end selection |
| 03/09/2000 | WO2000012506A2 Collections of compounds |
| 03/09/2000 | CA2335102A1 Benzodiazepines and benzothiazepines derivatives and hbsag peptides binding to annexins, their compositions and use |
| 03/08/2000 | EP0983290A1 Method for producing polymers having nucleo-bases as side-groups |